| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 10%+ Owner | Common Stock | 3,848,632 | $16,741,549 | $4.35 | 26 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics, Inc. | 26 Jun 2023 | 1 | -$206 | 4 | 10%+ Owner | 28 Jun 2023, 15:47 |
| ACRV | Acrivon Therapeutics, Inc. | 15 Jun 2023 | 1 | -$24,959 | 4 | 10%+ Owner | 20 Jun 2023, 17:15 |
| ACRV | Acrivon Therapeutics, Inc. | 12 Jun 2023 | 3 | -$72,412 | 4 | 10%+ Owner | 14 Jun 2023, 18:33 |
| ACRV | Acrivon Therapeutics, Inc. | 17 Nov 2022 | 5 | $5,000,000 | 4 | 10%+ Owner | 21 Nov 2022, 17:26 |
| ACRV | Acrivon Therapeutics, Inc. | 09 Nov 2022 | 0 | $0 | 3/A | 10%+ Owner | 14 Nov 2022, 20:04 |